Feb 24, 2022 / 10:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the AbCellera Full Year 2021 Earnings Results and Business Update. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to turn the conference over to Tryn Stimart, Chief Legal and Compliance Officer. Please go ahead.
Tryn T. Stimart - AbCellera Biologics Inc. - Chief Legal Officer, Chief Compliance Officer & Corporate Secretary
Thank you. Good afternoon, and welcome to AbCellera's Full Year 2021 business update. We are pleased to have you with us today, where we will discuss the results announced in our press release issued after the market closed today, which you can find on our Investor Relations website.
With me on the call are Dr. Carl Hansen, AbCellera's Chief Executive Officer and President; and Andrew Booth, AbCellera's Chief Financial Officer. The webcast portion of this call contains a slide presentation that we will refer to during the call. If you are following along on the phone and wish to access the slide portion of this
Q4 2021 Abcellera Biologics Inc Earnings Call Transcript
Feb 25, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers